HIGHLIGHTS
- who: Zhe Xu Cao from the Geneis (Beijing) CoLtd, China Soochow University, China have published the research: Receptor–ligand pair typing and prognostic risk model for papillary thyroid carcinoma based on single-cell sequencing, in the Journal: (JOURNAL)
- how: Differences in activated pathways were compared among three molecular subtypes and results showed that some immunerelated pathways were activated in the C1 subtype than in the C2 subtype. The results showed that LR.score was negatively correlated with MC in the resting phase suggesting that the inhibition of MCs and their mediators may be a new . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.